@article{44698c3bc59f4ed586fbda34a38f22db,
title = "Fetal growth velocity standards from the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project",
abstract = "Background: Human growth is susceptible to damage from insults, particularly during periods of rapid growth. Identifying those periods and the normative limits that are compatible with adequate growth and development are the first key steps toward preventing impaired growth. Objective: This study aimed to construct international fetal growth velocity increment and conditional velocity standards from 14 to 40 weeks{\textquoteright} gestation based on the same cohort that contributed to the INTERGROWTH-21st Fetal Growth Standards. Study Design: This study was a prospective, longitudinal study of 4321 low-risk pregnancies from 8 geographically diverse populations in the INTERGROWTH-21st Project with rigorous standardization of all study procedures, equipment, and measurements that were performed by trained ultrasonographers. Gestational age was accurately determined clinically and confirmed by ultrasound measurement of crown-rump length at <14 weeks{\textquoteright} gestation. Thereafter, the ultrasonographers, who were masked to the values, measured the fetal head circumference, biparietal diameter, occipitofrontal diameter, abdominal circumference, and femur length in triplicate every 5 weeks (within 1 week either side) using identical ultrasound equipment at each site (4–7 scans per pregnancy). Velocity increments across a range of intervals between measures were modeled using fractional polynomial regression. Results: Peak velocity was observed at a similar gestational age: 16 and 17 weeks{\textquoteright} gestation for head circumference (12.2 mm/wk), and 16 weeks{\textquoteright} gestation for abdominal circumference (11.8 mm/wk) and femur length (3.2 mm/wk). However, velocity growth slowed down rapidly for head circumference, biparietal diameter, occipitofrontal diameter, and femur length, with an almost linear reduction toward term that was more marked for femur length. Conversely, abdominal circumference velocity remained relatively steady throughout pregnancy. The change in velocity with gestational age was more evident for head circumference, biparietal diameter, occipitofrontal diameter, and femur length than for abdominal circumference when the change was expressed as a percentage of fetal size at 40 weeks{\textquoteright} gestation. We have also shown how to obtain accurate conditional fetal velocity based on our previous methodological work. Conclusion: The fetal skeleton and abdomen have different velocity growth patterns during intrauterine life. Accordingly, we have produced international Fetal Growth Velocity Increment Standards to complement the INTERGROWTH-21st Fetal Growth Standards so as to monitor fetal well-being comprehensively worldwide. Fetal growth velocity curves may be valuable if one wants to study the pathophysiology of fetal growth. We provide an application that can be used easily in clinical practice to evaluate changes in fetal size as conditional velocity for a more refined assessment of fetal growth than is possible at present (https://lxiao5.shinyapps.io/fetal_growth/). The application is freely available with the other INTERGROWTH-21st tools at https://intergrowth21.tghn.org/standards-tools/.",
keywords = "correlation models, fetal growth, fetal growth velocity, fetal velocity standards, longitudinal study",
author = "{International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st Project)} and Ohuma, {Eric O.} and Jos{\'e} Villar and Yuan Feng and Luo Xiao and Laurent Salomon and Barros, {Fernando C.} and {Cheikh Ismail}, Leila and William Stones and Yasmin Jaffer and Manuela Oberto and Noble, {J. Alison} and Gravett, {Michael G.} and Qingqing Wu and Victora, {Cesar G.} and Ann Lambert and {Di Nicola}, Paola and Manorama Purwar and Bhutta, {Zulfiqar A.} and Kennedy, {Stephen H.} and Papageorghiou, {Aris T.} and M. Katz and Bhan, {M. K.} and C. Garza and S. Zaidi and A. Langer and Rothwell, {P. M.} and Weatherall, {Sir D.} and S. Kennedy and Altman, {D. G.} and E. Bertino and F. Burton and M. Carvalho and Chumlea, {W. C.} and Jaffer, {Y. A.} and P. Lumbiganon and Pang, {R. Y.} and J. Rivera and M. Shorten and L. Hoch and Knight, {H. E.} and C. Cosgrove and I. Blakey and F. Roseman and N. Kunnawar and Gu, {S. H.} and Wang, {J. H.} and Wu, {M. H.} and M. Domingues and S. Vinayak and S. Wanyonyi",
note = "Funding Information: A.T.P. is supported by the Oxford Partnership Comprehensive Biomedical Research Centre, with funding from the National Institute for Health Research Biomedical Research Centre funding scheme. This project was supported by a generous grant from the Bill & Melinda Gates Foundation (grant no. 49038) to the University of Oxford. The funder played no role in the study design, analysis, or paper preparation.This project was supported by a generous grant from the Bill & Melinda Gates Foundation to the University of Oxford, for which we are very grateful. We thank the health authorities in Pelotas, Brazil; Beijing, China; Nagpur, India; Turin, Italy; Nairobi, Kenya; Muscat, Oman; Oxford, United Kingdom; and Seattle, WA, who helped with the project by allowing participation of these study sites as collaborating centers. We thank Philips Healthcare for providing the ultrasound equipment and technical assistance throughout the project and MedSciNet UK for setting up the INTERGROWTH-21st website and for the development, maintenance, and support of the online data management system. We also thank the parents and infants who participated in the studies and the more than 200 members of the research teams who made the implementation of this project possible. The participating hospitals included the following: Brazil, Pelotas (Hospital Miguel Piltcher, Hospital S{\~a}o Francisco de Paula, Santa Casa de Miseric{\'o}rdia de Pelotas, and Hospital Escola da Universidade Federal de Pelotas); China, Beijing (Beijing Obstetrics and Gynecology Hospital, Shunyi Maternal and Child Health Centre, and Shunyi General Hospital); India, Nagpur (Ketkar Hospital, Avanti Institute of Cardiology, Avantika Hospital, Gurukrupa Maternity Hospital, Mulik Hospital and Research Centre, Nandlok Hospital, Om Women's Hospital, Renuka Hospital and Maternity Home, Saboo Hospital, Brijmohan Taori Memorial Hospital, and Somani Nursing Home); Kenya, Nairobi (Aga Khan University Hospital, MP Shah Hospital, and Avenue Hospital); Italy, Turin (Ospedale Infantile Regina Margherita Sant{\textquoteright} Anna and Azienda Ospedaliera Ordine Mauriziano); Oman, Muscat (Khoula Hospital, Royal Hospital, Wattayah Obstetrics and Gynaecology Poly Clinic, Wattayah Health Center, Ruwi Health Center, Al Ghubra Health Center, and Al Khuwair Health Center); United Kingdom, Oxford (John Radcliffe Hospital) and United States, Seattle (University of Washington Hospital, Swedish Hospital, and Providence Everett Hospital). Full acknowledgment of all those who contributed to the development of the INTERGROWTH-21st Project is online and in the Appendix. Members of the International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st) and its Committees, Scientific Advisory Committee, M. Katz (Chair from January 2011), M.K. Bhan, C. Garza, S. Zaidi, A. Langer, P.M. Rothwell (from February 2011), and Sir D. Weatherall (Chair until December 2010). Steering Committee, Z.A. Bhutta (Chair), J. Villar (Principal Investigator), S. Kennedy (Project Director), D.G. Altman, F.C. Barros, E. Bertino, F. Burton, M. Carvalho, L. Cheikh Ismail, W.C. Chumlea, M.G. Gravett, Y.A. Jaffer, A. Lambert, P. Lumbiganon, J.A. Noble, R.Y. Pang, A.T. Papageorghiou, M. Purwar, J. Rivera, and C. Victora. Executive Committee, J. Villar (Chair), D.G. Altman (deceased 2018), Z.A. Bhutta, L. Cheikh Ismail, S. Kennedy, A. Lambert, J.A. Noble, and A.T. Papageorghiou. Project Coordinating Unit, J. Villar (Head), S. Kennedy, L. Cheikh Ismail, A. Lambert, A.T. Papageorghiou, M. Shorten, L. Hoch (until May 2011), H.E. Knight (until August 2011), E.O. Ohuma (from September 2010), C. Cosgrove (from July 2011), and I. Blakey (from March 2011). Data Analysis Group, D.G. Altman (Head), E.O. Ohuma, and J. Villar. Data Management Group, D.G. Altman (Head), F. Roseman, N. Kunnawar, S.H. Gu, J.H. Wang, M.H. Wu, M. Domingues, P. Gilli, L. Juodvirsiene, L. Hoch (until May 2011), N. Musee (until June 2011), H. Al-Jabri (until October 2010), S. Waller (until June 2011), C. Cosgrove (from July 2011), D. Muninzwa (from October 2011), E.O. Ohuma (from September 2010), D. Yellappan (from November 2010), A. Carter (from July 2011), D. Reade (from June 2012), and R. Miller (from June 2012). Ultrasound Group, A.T. Papageorghiou (Head), L. Salomon (Senior External Advisor), A. Leston, A. Mitidieri, F. Al-Aamri, W. Paulsene, J. Sande, W.K.S. Al-Zadjali, C. Batiuk, S. Bornemeier, M. Carvalho, M. Dighe, P. Gaglioti, N. Jacinta, S. Jaiswal, J.A. Noble, K. Oas, M. Oberto, E. Olearo, M.G. Owende, J. Shah, S. Sohoni, T. Todros, M. Venkataraman, S. Vinayak, L. Wang, D. Wilson, Q.Q. Wu, S. Zaidi, Y. Zhang, P. Chamberlain (until September 2012), D. Danelon (until July 2010), I. Sarris (until June 2010), J. Dhami (until July 2011), C. Ioannou (until February 2012), C.L. Knight (from October 2010), R. Napolitano (from July 2011), S. Wanyonyi (from May 2012), C. Pace (from January 2011), and V. Mkrtychyan (from June 2012). Anthropometry Group, L. Cheikh Ismail (Head), W.C. Chumlea (Senior External Advisor), F. Al-Habsi, Z.A. Bhutta, A. Carter, M. Alija, J.M. Jimenez-Bustos, J. Kizidio, F. Puglia, N. Kunnawar, H. Liu, S. Lloyd, D. Mota, R. Ochieng, C. Rossi, M. Sanchez Luna, Y.J. Shen, H.E. Knight (until August 2011), D.A. Rocco (from June 2012), and I.O. Frederick (from June 2012). Neonatal Group, Z.A. Bhutta (Head), E. Albernaz, M. Batra, B.A. Bhat, E. Bertino, P. Di Nicola, F. Giuliani, I. Rovelli, K. McCormick, R. Ochieng, R.Y. Pang, V. Paul, V. Rajan, A. Wilkinson, and A. Varalda (from September 2012). Environmental Health Group, B. Eskenazi (Head), L.A. Corra, H. Dolk, J. Golding, A. Matijasevich, T. de Wet, J.J. Zhang, A. Bradman, D. Finkton, O. Burnham, and F. Farhi. Participating countries and local investigators, Brazil: F.C. Barros (Principal Investigator), M. Domingues, S. Fonseca, A. Leston, A. Mitidieri, D. Mota, I.K. Sclowitz, and M.F. da Silveira. China: R.Y. Pang (Principal Investigator), Y.P. He, Y. Pan, Y.J. Shen, M.H. Wu, Q.Q. Wu, J.H. Wang, Y. Yuan, and Y. Zhang. India: M. Purwar (Principal Investigator), A. Choudhary, S. Choudhary, S. Deshmukh, D. Dongaonkar, M. Ketkar, V. Khedikar, N. Kunnawar, C. Mahorkar, I. Mulik, K. Saboo, C. Shembekar, A. Singh, V. Taori, K. Tayade, and A. Somani. Italy: E. Bertino (Principal Investigator), P. Di Nicola, M. Frigerio, G. Gilli, P. Gilli, M. Giolito, F. Giuliani, M. Oberto, L. Occhi, C. Rossi, I. Rovelli, F. Signorile, and T. Todros. Kenya: W. Stones and M. Carvalho (Coprincipal Investigators), J. Kizidio, R. Ochieng, J. Shah, S. Vinayak, N. Musee (until June 2011), C. Kisiang'ani (until July 2011), and D. Muninzwa (from August 2011). Oman: Y.A. Jaffer (Principal Investigator), J. Al-Abri, J. Al-Abduwani, F.M. Al-Habsi, H. Al-Lawatiya, B. Al-Rashidiya, W.K.S. Al-Zadjali, F.R. Juangco, M. Venkataraman, H. Al-Jabri (until October 2010), and D. Yellappan (from November 2010). United Kingdom: S. Kennedy (Principal Investigator), L. Cheikh Ismail, A.T. Papageorghiou, F. Roseman, A. Lambert, E.O. Ohuma, S. Lloyd, R. Napolitano (from July 2011), C. Ioannou (until February 2012), and I. Sarris (until June 2010). United States: M.G. Gravett (Principal Investigator), C. Batiuk, M. Batra, S. Bornemeier, M. Dighe, K. Oas, W. Paulsene, D. Wilson, I.O. Frederick, H.F. Andersen, S.E. Abbott, A.A. Carter, H. Algren, D.A. Rocco, T.K. Sorensen, D. Enquobahrie, and S. Waller (until June 2011). Funding Information: A.T.P. is supported by the Oxford Partnership Comprehensive Biomedical Research Centre , with funding from the National Institute for Health Research Biomedical Research Centre funding scheme. This project was supported by a generous grant from the Bill & Melinda Gates Foundation (grant no. 49038) to the University of Oxford. The funder played no role in the study design, analysis, or paper preparation. Publisher Copyright: {\textcopyright} 2020 The Authors",
year = "2021",
month = feb,
doi = "10.1016/j.ajog.2020.07.054",
language = "English",
volume = "224",
pages = "208.e1--208.e18",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "2",
}